|

Oxaliplatin 130mg/m2 + Capecitabine 1000mg/m2 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CAPOX

Pipeline

Phase 2: 1

Top Sponsors

  • Baylor College of Medicine1

Indications

  • Stage III Colon Cancer1
  • Stage II Colon Cancer1
  • Stage I Colon Cancer1
  • Cancer1

Houston, Texas1 trial

Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER

Baylor College of Medicine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.